Matches in Nanopublications for { ?s ?p "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_provenance.
- NP432172.RAlYmnq1EXQpAzoDVslQpdjAGQHpIoGw6-NWv5fwDf0kg130_assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432172.RAlYmnq1EXQpAzoDVslQpdjAGQHpIoGw6-NWv5fwDf0kg130_provenance.
- assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1010530.RABr1aJz-sVvU3xs_h7lJDhe7pwtWdocP7IaVKn9WXYX4130_assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010530.RABr1aJz-sVvU3xs_h7lJDhe7pwtWdocP7IaVKn9WXYX4130_provenance.
- NP624222.RAWZTAh1hV1-Ws7wpZD7EBBtR1quv-TJSmUIsAJDImxPE130_assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624222.RAWZTAh1hV1-Ws7wpZD7EBBtR1quv-TJSmUIsAJDImxPE130_provenance.
- NP1010726.RAPLoWGn6dD4t61RNH7Ma6Ee-IEsCmnEK3EL97vgXIKqA130_assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010726.RAPLoWGn6dD4t61RNH7Ma6Ee-IEsCmnEK3EL97vgXIKqA130_provenance.
- NP624218.RAGNSiO9Re8u-eDp7gUiFHWAUMcY6H2RgmQHUHt-eB7AE130_assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624218.RAGNSiO9Re8u-eDp7gUiFHWAUMcY6H2RgmQHUHt-eB7AE130_provenance.